Biosimilars are billed differently than generics under Medicare Part B. Learn how coding, payment calculations, and the JZ modifier affect reimbursement-and why adoption remains low despite lower drug costs.
Explore how fungi are reshaping biotechnology, from enzymes and biofuels to mycelium materials, and discover emerging tools, scaling challenges, and future trends.